A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells
TRANSFUSION AND APHERESIS SCIENCE, cilt.47, sa.1, ss.67-75, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 1
- Basım Tarihi: 2012
- Doi Numarası: 10.1016/j.transci.2012.05.003
- Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.67-75
- Anahtar Kelimeler: Steady state CD34, Stem cell, Mobilization, Multiple myeloma, Lymphoma, NON-HODGKINS-LYMPHOMA, MULTIPLE-MYELOMA, BLOOD, COLLECTION, TRANSPLANTATION, CHEMOTHERAPY, ENUMERATION, CIRCULATION, CD34+CELLS, PREDICTS
- Ankara Üniversitesi Adresli: Evet
Özet
Predicting success of hematopoietic cell mobilization is an important issue for transplant physicians. We examined the steady state peripheral blood CD34+ cell count to predict ability to mobilize adequate hematopoietic progenitor cells in 63 myeloma and lymphoma patients. The median steady state CD34+ cell number was 1.56/mu L (0.03-5.76). Although counting steady state CD34+ is definitely cost effective to predict the successful mobilization, we could not find a threshold steady state CD34 count of any value predicting successful mobilization. (C) 2012 Elsevier Ltd. All rights reserved.